Sterling Capital Management LLC Takeda Pharmaceutical CO LTD Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Sterling Capital Management LLC holds 33,730 shares of TAK stock, worth $457,716. This represents 0.01% of its overall portfolio holdings.
Number of Shares
33,730
Previous 22,165
52.18%
Holding current value
$457,716
Previous $381,000
125790.03%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TAK
# of Institutions
322Shares Held
71.1MCall Options Held
939KPut Options Held
233K-
Capital Research Global Investors Los Angeles, CA13.1MShares$178 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.35MShares$72.7 Million0.01% of portfolio
-
Mondrian Investment Partners LTD London, X05.09MShares$69.1 Million1.21% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.64MShares$62.9 Million0.05% of portfolio
-
Goldman Sachs Group Inc New York, NY4.56MShares$61.9 Million0.01% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $42.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...